NCCN Foundation awards leading young investigators advancing cancer research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Comprehensive Cancer Network and the NCCN Foundation announced five new recipients for the 10th annual NCCN Foundation Young Investigator Awards Program.

The honorees will receive up to $150,000 in funding to study ways to improve care and help find cures for people with breast, colorectal, pancreatic, and small cell lung cancer, as well as pediatric acute myeloid leukemia. The NCCN Oncology Research Program managed the selection process and will oversee the projects, which will each extend for the next two years.

The 2020 NCCN Foundation YIA recipients are:

  • Agnieszka Czechowicz, assistant professor of pediatrics, Stanford University School of Medicine: “Development of anti-hKIT Chimeric Antigen Receptor T-Cells as a Dual Hematopoietic Stem Cell Transplantation Conditioning and Immunotherapeutic Agent for Cure of Pediatric Acute Myeloid Leukemia.”

  • Wade T. Iams, assistant professor of medicine, Vanderbilt University Medical Center: “Quantifying Minimal Residual Disease in Patients with Small Cell Lung Cancer.”

  • Shivan Mehta, assistant professor of medicine, University of Pennsylvania: “Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting.”

  • Mustafa Raoof, assistant clinical professor, City of Hope Beckman Research Institute: “Targeting Transcription-Replication Conflicts in KRAS-driven Pancreatic Cancer.”

  • Jennifer Y. Sheng, assistant professor in oncology, Johns Hopkins University School of Medicine: “An Adaptive Nutrition and Exercise Weight loss (A-NEW) Study for Breast Cancer Survivors.”

Table of Contents

YOU MAY BE INTERESTED IN

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login